- Home
- FENG vs VTVT Comparison
FENG vs VTVT Comparison
Compare FENG & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- VTVT
- Stock Information
- Founded
- FENG 1998
- VTVT 2015
- Country
- FENG China
- VTVT United States
- Employees
- FENG N/A
- VTVT N/A
- Industry
- FENG Broadcasting
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- FENG Industrials
- VTVT Health Care
- Exchange
- FENG Nasdaq
- VTVT Nasdaq
- Market Cap
- FENG 37.6M
- VTVT 31.9M
- IPO Year
- FENG 2011
- VTVT 2015
- Fundamental
- Price
- FENG $2.43
- VTVT $15.64
- Analyst Decision
- FENG
- VTVT
- Analyst Count
- FENG 0
- VTVT 0
- Target Price
- FENG N/A
- VTVT N/A
- AVG Volume (30 Days)
- FENG 5.8K
- VTVT 48.4K
- Earning Date
- FENG 11-12-2024
- VTVT 11-12-2024
- Dividend Yield
- FENG N/A
- VTVT N/A
- EPS Growth
- FENG N/A
- VTVT N/A
- EPS
- FENG N/A
- VTVT N/A
- Revenue
- FENG $99,426,474.00
- VTVT $1,000,000.00
- Revenue This Year
- FENG N/A
- VTVT N/A
- Revenue Next Year
- FENG N/A
- VTVT N/A
- P/E Ratio
- FENG N/A
- VTVT N/A
- Revenue Growth
- FENG N/A
- VTVT 11011.11
- 52 Week Low
- FENG $1.20
- VTVT $7.38
- 52 Week High
- FENG $4.15
- VTVT $30.99
- Technical
- Relative Strength Index (RSI)
- FENG 41.29
- VTVT 60.33
- Support Level
- FENG $2.41
- VTVT $12.62
- Resistance Level
- FENG $2.98
- VTVT $15.40
- Average True Range (ATR)
- FENG 0.18
- VTVT 0.85
- MACD
- FENG -0.03
- VTVT 0.12
- Stochastic Oscillator
- FENG 19.67
- VTVT 92.13
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.